Services
Development Services
Formulation
Solubility & Bioavailability Enhancement
Nanotechnology
Drug / Device Combination Products
Biopharmaceutical
Proprietary Technology
Feasibility Programs
Manufacturing Services
Aseptic Manufacturing
Pre-clinical Manufacturing
Clinical Manufacturing
Commercial Manufacturing
ICH Stability Programs
Analytical Services
Analytical Method Development and Validation
Drug Release Testing
Physical Characterization
Stability Indicating Method Development
Dosage Forms
Solutions and Suspensions
Implantable Drug Delivery Systems and Combination Products
Oral Solid Dose
Semi-Solids and Gels
Powders
Markets Served
Ophthalmic
Long-Acting Drug Delivery
Oral Drug Delivery
Topical, Mucosal, and Transdermal
Injectables / Parenteral
Resource Center
Our Blog
Case Studies
Guides
Brochures
Published Articles
Scientific Publications
Technical Briefs
Webinars / Podcast / Presentations
About Us
Employment
Events
Management Team
Press Releases
Contact Us
Services
Development Services
Formulation
Solubility & Bioavailability Enhancement
Nanotechnology
Drug / Device Combination Products
Biopharmaceutical
Proprietary Technology
Feasibility Programs
Manufacturing Services
Aseptic Manufacturing
Pre-clinical Manufacturing
Clinical Manufacturing
Commercial Manufacturing
ICH Stability Programs
Analytical Services
Analytical Method Development and Validation
Drug Release Testing
Physical Characterization
Stability Indicating Method Development
Dosage Forms
Solutions and Suspensions
Implantable Drug Delivery Systems and Combination Products
Oral Solid Dose
Semi-Solids and Gels
Powders
Markets Served
Ophthalmic
Long-Acting Drug Delivery
Oral Drug Delivery
Topical, Mucosal, and Transdermal
Injectables / Parenteral
Resource Center
Our Blog
Case Studies
Guides
Brochures
Published Articles
Scientific Publications
Technical Briefs
Webinars / Podcast / Presentations
About Us
Employment
Events
Management Team
Press Releases
Contact Us
Premium Tech Briefs
Incorporation of Dexamethasone Into Silicone Drug-Device Combination Products
Combination Products for Medical Device Developers
Lyophilization of Complex Drug Products: Formulation Challenges and Scale-Up
Manufacturing Sterile Products
Ophthalmic Drug Delivery for Retinal Disorders
Hot Melt Extrusion for Oral Solid Dosage Forms
Dosage Forms / Methods Tech Briefs
Biopharmaceutical
Biopharmaceutical Classification System
Protein Structure: Primary, Secondary, Tertiary, Quatemary Structures
Drug Eluting Device/ Implantables
Solid Solutions and Dispersions
Potent Compound Handling Operations
Hot Melt Extrusion
Glossary of Polymer Terms
Dissolving Films
Combination Devices
Injectables
Emulsions and Emulsifications
Lipidic Systems
Solid Lipid Nanoparticles
Phase Behavior of Surface-Active Solutes
Cubic Phase Particles
Emulsion Stability and Testing
Surfactants
Emulsions and Emulsifications
Micro & Nanotechnology
Considerations in Particle Sizing – Part 1: Classification of the Various Sizing Techniques
Physical Stability of Disperse Systems
Solid Lipid Nanoparticles
Glossary of Nanotech
Nanotechnology – New Name – Old Science
Encapsulation
Mechanical Dispersing of Insoluble APIs
Considerations in Particle Sizing – Part 2: Specifying a Particle Size Analyzer
Oral
In Vitro Dissolution Testing For Solid Oral Dosage Forms
Physical Stability of Disperse Systems
Solid Solutions and Dispersions
Hot Melt Extrusion
Dissolving Films
Topicals
Surfactants
Development and Validation of In Vitro Release Testing for Semisolid Formulations
Skin and Nail: Barrier Function, Structure, and Anatomy Considerations for Drug Delivery
Intellectual Property
The Patent Process
Services Offered Tech Briefs
Prefomulation
Considerations in Particle Sizing – Part 1: Classification of the Various Sizing Techniques
Physical Stability of Disperse Systems
Drug Substance Solid State Characterization
Overview of the Zeta Potential
Solubility – Ideal Solubility & Solubility Models
Sampling of Powders
Considerations in Particle Sizing – Part 2: Specifying a Particle Size Analyzer
Particle Size Distribution and Its Measurement
Formulation Development
Targeted Therapeutics and Nanoparticles
In Vitro Dissolution Testing For Solid Oral Dosage Forms
Drug Substance Solid State Characterization
Biopharmaceutical Classification System
Solid Lipid Nanoparticles
Glossary of Nanotech
Quality by Design
Phase Behavior of Surface-Active Solutes
Cubic Phase Particles
Solid Solutions and Dispersions
Overview of the Zeta Potential
Nanotechnology – New Name – Old Science
Solubility – Ideal Solubility & Solubility Models
Sampling of Powders
Potent Compound Handling Operations
Hot Melt Extrusion
Emulsion Stability and Testing
Glossary of Polymer Terms
Encapsulation
Mechanical Dispersing of Insoluble APIs
Dissolution Testing for OSD
The Patent Process
Dissolving Films
Combination Devices
Surfactants
Emulsions and Emulsifications
Skin and Nail: Barrier Function, Structure, and Anatomy Considerations for Drug Delivery
Manufacturing
Quality by Design
Process Analytical Technology
Potent Compound Handling Operations
Analytical
Considerations in Particle Sizing – Part 1: Classification of the Various Sizing Techniques
In Vitro Dissolution Testing For Solid Oral Dosage Forms
Drug Substance Solid State Characterization
Process Analytical Technology
Overview of the Zeta Potential
Sampling of Powders
Emulsion Stability and Testing
Development and Validation of In Vitro Release Testing for Semisolid Formulations
Protein Structure: Primary, Secondary, Tertiary, Quatemary Structures
Considerations in Particle Sizing – Part 2: Specifying a Particle Size Analyzer
Analytical Method Development and Validation
Mass Spectrometry in Bioanalysis
Particle Size Distribution and Its Measurement
Pharmacokinetics
Mass Spectrometry in Bioanalysis
Quality & Regulatory
Code of Federal Regulations Title 21 Part 11 Requirements
Quality by Design
Analytical Method Development and Validation